Segmental endobronchial valve therapy for a vasculitis-induced emphysema.

Emphysema Hypocomplementaemic urticarial vasculitis syndrome Segmental valve implantation Valve implantation Vasculitis

Journal

Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463

Informations de publication

Date de publication:
2022
Historique:
received: 21 12 2021
revised: 25 03 2022
accepted: 08 04 2022
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

A 53-year old female patient with history of hypocomplementaemic urticarial vasculitis syndrome (HUVS) and polyarteritis nodosa presented with progressive dyspnoea on exertion due to emphysema. Lung function revealed a severe obstructive ventilator disorder with a forced expiratory volume in 1 second of 22% of predicted, and a significant hyperinflation with a residual volume of 321% of predicted. Multi-detector computed tomography (MDCT) scan and quantitative CT analysis (StratX software) confirmed a lower lobe predominant emphysema. Considering the young age, the very severely impaired lung function, the relatively low nicotine abuse, the exclusion of alpha-1 antitrypsin deficiency, together with the known diagnosis of HUVS, the emphysema was more likely due to the vasculitis than to a typical chronic obstructive lung disease. MDCT scan showed that particularly the segment 8 of the right lower lobe was severely emphysematous destroyed and hyperinflated. Invasive Chartis® measurement revealed no significant collateral ventilation of the isolated segment 8 of the right lower lobe, so that an endobronchial valve placement was performed. Three months following intervention, the MDCT scan revealed a complete collapse of the segment 8 on the right, which was associated with a significant clinical benefit and a mild reduction of the hyperinflation in the lung function test.

Identifiants

pubmed: 35494554
doi: 10.1016/j.rmcr.2022.101650
pii: S2213-0071(22)00072-7
pmc: PMC9048058
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101650

Informations de copyright

© 2022 The Authors. Published by Elsevier Ltd.

Références

Sarcoidosis Vasc Diffuse Lung Dis. 2006 Mar;23(1):70-2
pubmed: 16933473
J Thorac Dis. 2018 Sep;10(9):5560-5575
pubmed: 30416807
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164
pubmed: 29787288
Lung India. 2015 Jul-Aug;32(4):367-9
pubmed: 26180387
Respiration. 2017;93(2):138-150
pubmed: 27992862
Clin Exp Immunol. 1999 Apr;116(1):4-8
pubmed: 10209498
Respiration. 2013;85(6):515-20
pubmed: 23485627
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
J Clin Immunol. 2013 Jul;33(5):891-5
pubmed: 23615811
World Allergy Organ J. 2020 Mar 05;13(3):100107
pubmed: 32180892
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809

Auteurs

Christina Bal (C)

Department of Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria.

Lisa Göschl (L)

Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Ruxandra-Iulia Milos (RI)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Klaus Gerstbrein (K)

Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.

Andreas Kerschbaumer (A)

Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.

Marco Idzko (M)

Department of Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria.

Daniela Gompelmann (D)

Department of Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria.

Classifications MeSH